Search News

Corporate Industry Technology Medical Updates

NyokAssist

Corporate
National Recognition: magAssist Certified as a High-Tech Enterprise, Strengthening the Foundation of Domestic Multi-Organ Life Support Innovation 2025-12-02
Corporate
From China to the Global Stage: magAssist Selected Among Fortune’s 23 Featured Healthcare Companies 2025-11-15
Industry
Redefining What's Possible in HRPCI — TCT 2025 Clinical Exchange on NyokAssist™ 2025-10-29
Corporate
magAssist Recognized as a 2025 Potential Unicorn Enterprise in Jiangsu 2025-09-30
Corporate
magAssist Shortlisted for 2025 Prix Galien USA Best Start-Up Award 2025-08-14
Corporate
magAssist was included in the catalogue of "Advantageous Enterprises in the Fourth Batch of Intellectual Property Strong Companies Cultivation Project in Suzhou City". 2024-12-20
Industry
TCT 2024 | NyokAssist® Makes Global Debut as a Novel Interventional Ventricular Assist Device 2024-11-01
Medical Updates
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi 2023-08-23
Corporate
magAssist's NyokAssist™ granted Designation by the FDA as a Breakthrough Device 2023-08-17
Corporate
FDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device 2023-08-17

Tabs： DonorLife Organ Care System, ISMCS, the first domestically developed extra-VAD, Forbes, the warm blood donor heart transport system, heart failure device, high-risk PCI intraoperative protection, IFAO, lifesaving technology,